Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions

Clinical trial NCT06192589 · COMPLETED

Trial details

NCT number: NCT06192589
Sponsor: Food and Drug Administration (FDA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cannabidiol Drug Induced Liver Injury Drug Interaction

Start date: 2024-02-08
Primary completion: 2024-09-06
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.